Claudio U. Koser - Publications

Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

Journal: Microbiology spectrum

Published: August 26, 2026

Understanding systematic rifampicin resistance errors with the FluoroType MTBDR VER 2.0.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: December 18, 2025

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 12, 2025

In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: September 22, 2025

Quality control and considering systematic MIC shifts are key when evaluating the role of mmpR5 (Rv0678) frameshifts in bedaquiline resistance.

Journal: Antimicrobial agents and chemotherapy

Published: August 14, 2025

The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: April 22, 2025

All parts of the WHO Mycobacterium tuberculosis mutation catalog need to be applied when evaluating its performance.

Journal: Microbiology spectrum

Published: April 02, 2025

More nuance and transparency are needed when setting breakpoints for antimicrobial susceptibility testing of pretomanid.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 12, 2024

Careful classification of potential bedaquiline resistance mutations is critical when analysing their clinical impact.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 01, 2024

The exceptions that prove the rule-a historical view of bedaquiline susceptibility.

Journal: Genome medicine

Published: February 29, 2024

A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex.

Journal: The European respiratory journal

Published: February 29, 2024

Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid.

Journal: Microbiology spectrum

Published: February 09, 2024